BeStock  
Stocks › Biotechnology › ADRX

Adarx Pharmaceuticals ADRX

US equityMarket cap rank #2910Biotechnology
$12.79 −$1.37 (-9.68%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $12.79 0.00%
Open$14.03
Prev close$14.16
Day range$12.63 – $14.87
Volume708.8K
Market cap$1.42B
P/E (TTM)–
Dividend yield–

ADRX Stock News

Headlines matching Adarx Pharmaceuticals or the ADRX ticker, most recent first.

  • Emerging siRNA developer ADARx (ADRX.US) has launched a $350 million IPO, with AbbVie subscribing to a 4.9% stake and committing up to $100 million.Zhitong Finance · 22 Sep 2026 · Direct mention
  • Earnings Flash (ADRX) ADARx Pharmaceuticals, Inc. Reports Q3 Revenue $2.2M, Vs. FactSet Est of $2.6MMT Newswires · 13 Nov 2026 · Direct mention
  • A Quick Look at Today's Ratings for Adarx Pharmaceuticals(ADRX.US), With a Forecast Between $32 to $38Market news · 21 Oct 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on ADRX.

Sign in to join the discussion.

Scroll to Top